| 陈燕,要金元.不同频次火针治疗积液性膝骨关节炎 44例[J].安徽医药,2026,30(11):2281-2285. |
| 不同频次火针治疗积液性膝骨关节炎 44例 |
| Clinical observation of fire needle therapy with different frequencies for 44 cases of effusive knee osteoarthritis |
| |
| DOI：10.3969/j.issn.1009-6469.2026.11.030 |
| 中文关键词: 骨关节炎，膝 频次 火针治疗 骨代谢 膝关节功能 |
| 英文关键词: Osteoarthritis,knee Frequencies Fire needle therapy Bone metabolism Knee joint function |
| 基金项目:山西省中医药管理局中医药科研课题( 2023ZYYB087) |
|
| 摘要点击次数: 0 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的研究不同频次火针治疗积液性膝骨关节炎( KOA)的临床疗效。方法选取 2020年 10月至 2022年 10月晋中市第一人民医院收治的积液性 KOA病人 87例，依据病案号末尾数字奇偶性分为观察组 44例、对照组 43例。两组均实施火针治疗，对照组每 4天治疗 1次，观察组每 2天治疗 1次，疗程均 28 d。对比两组治疗前后临床症状评分、血清骨代谢指标、膝关节功能评分、膝关节积液量及滑膜厚度。结果治疗后两组各项临床症状评分均较治疗前下降( P<0.05)；观察组疼痛肿胀评分由(4.95±0.29)分降至( 1.08±0.12)分、腰膝酸软评分由( 4.93±0.32)分降至( 1.11±0.09)分、屈伸不利评分由( 4.96±0.35)分降至(1.09±0.13)分、神疲乏力评分由( 4.94±0.28)分降至( 1.11±0.12)分，下降幅度大于对照组( P<0.05)。两组血清骨代谢指标均较治疗前升高( P<0.05)；观察组骨钙素( BGP)由( 5.24±0.39)μg/L升至( 7.73±0.82)μg/L、骨保护素( OPG)由( 118.81±23.45)ng/L升至( 214.82±33.73)ng/L、骨特异性碱性磷酸酶( BALP)由( 36.34±3.16)U/L升至( 54.18±5.22)U/L、Ⅰ型前胶原羧基末端肽( PICP)由( 110.56±10.42)μg/L升至( 152.65±8.91)μg/L，升高幅度优于对照组( P<0.05)。两组膝关节功能各项评分均高于治疗前( P<0.05)；观察组稳定性评分由( 10.86±2.47)分升至( 18.03±1.22)分、关节活动度评分由( 10.19±2.83)分升至( 18.27±1.54)分、肌力评分由( 10.97±2.61)分升至( 17.95±1.23)分、功能活动评分由( 10.04±2.31)分升至( 18.11±0.97)分，各项评分均高于对照组( P<0.05)。两组关节积液量、滑膜厚度治疗后均显著降低( P<0.05)；观察组关节积液量由( 10.22±0.76)mL降至( 5.15±0.96)mL，滑膜厚度由( 5.25±0.94)mm降至( 3.22±0.63)mm，两项指标均低于对照组( P<0.05)。结论高频次火针治疗可有效缓解积液性 KOA病人临床症状，调节血清骨代谢水平，改善膝关节功能，减少关节积液、抑制滑膜增生。 |
| 英文摘要: |
| Objective To observe the clinical efficacy of fire needle therapy with different treatment frequencies in patients with effu-sive knee osteoarthritis (KOA).Methods A total of 87 patients with effusive KOA admitted to Jinzhong First People's Hospital fromOctober 2020 to October 2022 were enrolled. They were divided into an observation group (n=44) and a control group (n=43) accordingto the parity of the last digit of their medical record numbers. Both groups received fire needle therapy; the control group was treatedonce every 4 days, while the observation group once every 2 days, with a total treatment course of 28 days.Clinical symptom scores, se-rum bone metabolism biomarkers, knee joint function scores, knee joint effusion volume and synovial thickness were compared betweenthe two groupsbefore and after treatment.Results After treatment, the clinical symptom scores of both groups were significantly lower than those before treatment (P<0.05). In the observation group, the pain and swelling score decreased from (4.95±0.29)points to (1.08±0.12)points, the lumbago and knee soreness and weakness score from (4.93±0.32)points to (1.11±0.09)points, the flexion and extensiondysfunction score from (4.96±0.35)points to (1.09±0.13)points, and the lassitude score from (4.94±0.28)points to (1.11±0.12)points,with a significantly greater reduction than those in the control group (P<0.05). The serum bone metabolism biomarkers of both groups were significantly elevated after treatment (P<0.05). In the observation group, osteocalcin (BGP) rose from (5.24±0.39)μg/L to (7.73±0.82)μg/L, osteoprotegerin (OPG) from (118.81±23.45)ng/L to (214.82±33.73)ng/L, bone-specific alkaline phosphatase (BALP) from (36.34±3.16)U/L to (54.18±5.22)U/L, and procollagen type I carboxy-terminal peptide (PICP) from (110.56±10.42)μg/L to (152.65±8.91)μg/L, with higher elevation amplitude than that in the control group (P<0.05). The knee joint function scores of both groups in-creased significantly after treatment (P<0.05). In the observation group, the stability score increased from (10.86±2.47)points to (18.03±1.22)points, the range of motion score from (10.19±2.83)points to (18.27±1.54)points, the muscle strength score from (10.97±2.61) points to (17.95±1.23)points, and the functional activity score from (10.04±2.31)points to (18.11±0.97)points, all higher than those in the control group (P<0.05). The joint effusion volume and synovial thickness of the two groups were significantly reduced after treat-ment (P<0.05).In the observation group, the effusion volumedecreased from (10.22±0.76)mL to (5.15±0.96)mL, and the synovial thick-ness from (5.25±0.94)mm to (3.22±0.63)mm, with both parameters being significantly lower than those in the control group (P<0.05). Conclusion High-frequency fire needle therapy can effectively alleviate clinical symptoms, regulate serum bone metabolism levels,improve knee joint function, reduce joint effusion and inhibit synovial hyperplasia in patients with effusive KOA. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
